Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Ovarian Neoplasms 32Breast Neoplasms 18Neoplasms 9Triple Negative Breast Neoplasms 8Neoplasm Metastasis 7Sarcoma 6Prostatic Neoplasms 6Fanconi Anemia, Complementation Group D1 6Pancreatic Neoplasms 5Endometrial Neoplasms 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Small Cell Lung Carcinoma 4Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Fallopian Tube Neoplasms 4Colorectal Neoplasms 4Sarcoma, Ewing 2Rhabdomyosarcoma 2Mesothelioma 2Head and Neck Neoplasms 2Glioma 2Glioblastoma 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Advanced Solid Tumours 2Advanced Solid Tumors 2Wilms Tumor 1

Interventions

Cyclophosphamide 20Trastuzumab 12Epirubicin 12Doxorubicin 12Docetaxel 11Paclitaxel 10Filgrastim 8Carboplatin 7Radiotherapy 6Bevacizumab 5Neoadjuvant Therapy 4Lapatinib 4Granulocyte Colony-Stimulating Factor 4Albumin-Bound Paclitaxel 4tipifarnib 3pertuzumab 3pegfilgrastim 3Thiotepa 3Taxes 3Tamoxifen 3Surgical Procedures, Operative 3Melphalan 3Fluorouracil 3Chemotherapy, Adjuvant 3Capecitabine 3130-nm albumin-bound paclitaxel 3Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Flow Cytometry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Inflammatory Breast Neoplasms × olaparib × Clear all
NCT02227082 2021-08-04

Olaparib and Radiotherapy in Inoperable Breast Cancer

The Netherlands Cancer Institute

Phase 1 Completed
7 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡